UPCOMING SESSIONS in ET
Wed, Apr 8, 2026
10:00 – 11:00 PM UTC
CAR-T Therapy for AL Amyloidosis: What’s New, What’s Real, and What’s Next Heather Landau Click To Register
UPCOMING SESSIONS in ET
Wed, Apr 8, 2026 · 10:00 – 11:00 PM UTC
CAR-T Therapy for AL Amyloidosis: What’s New, What’s Real, and What’s Next
Heather Landau
Click To Register
View all sessions

Systemic AA Amyloidosis Caused by Inflammatory Hepatocellular Adenoma

Published: Sep 19, 2018
Category
Scientific Articles
Key Information
Source
The New England Journal of Medicine
Year
2018
summary/abstract

A woman presented with AA amyloidosis that was found to be caused by a genetic lesion in an inflammatory hepatocellular adenoma that led to overproduction of interleukin-6. Resection of the liver tumor led to improvement in the symptoms of amyloidosis.

Abstract Source
https://www.ncbi.nlm.nih.gov/pubmed/30231230
Full Text Source
https://www.nejm.org/doi/full/10.1056/NEJMc1805673?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
DOI
10.1056/NEJMc1805673
Authors
Calderaro J, Letouzé E, Bayard Q, Boulai A, Renault V, Deleuze JF, Bestard O, Franco D, Zafrani ES, Nault JC, Moutschen M, Zucman-Rossi J
Organisation
Henri Mondor University Hospital, France; INSERM Unité 1162, France; Centre National de Recherche en Génomique Humaine, France; Bellvitge University Hospital, Spain; Antoine Béclère University Hospital, France; Liege University Hospital, Belgium

Tags